Laird Thermal Systems Releases Its Next Generation of Eco-Friendly Recirculating Chillers for Precise Temperature Control of Analytical, Medical and Industrial Equipment

Laird Thermal Systems announced they have released its next generation of eco-friendly recirculating chillers for precise temperature control of analytical, medical and industrial equipment.

The Nextreme Recirculating Chiller platform features high-quality components, environmentally friendly refrigerants, low-noise components and a user-friendly operator interface at a standard price. The new chiller utilizes high-performance variable speed motors for noise reduction, lower room heat input and reduced energy consumption by up to 50% compared to conventional compressor-based systems.

The Nextreme Recirculating Chiller platform is designed with a semi-open coolant system which offers several advantages including decreased bacterial growth and evaporation while still being easy to maintain. The chiller utilizes high quality components that minimize downtime and features sensor instrumentation that provides system status and the ability to integrate predictive maintenance / failure analysis. By using environmentally-friendly R513A refrigerant, it delivers similar performance with less than half the Global Warming Potential (GWP) compared to traditional hydrofluorocarbons (HFC) refrigerants.

“The Nextreme Chiller line is designed for OEMs, laboratories and research universities that need an energy-efficient chiller versatile enough to support the cooling needs of their entire equipment installation,” said Greg Ducharme, Product Director at Laird Thermal Systems. “Laboratory technicians, R&D engineers and equipment operators will appreciate the quiet, maintenance-free operation of the system, knowing it also has a lower environmental impact due to its refrigerant type and reduced energy consumption.”

The Nextreme Recirculating Chiller platform cools well below ambient temperature and offers temperature stability of ±0.1°C of the designated temperature. The Nextreme Chiller Series is available with three standard cooling capacities including 1800 W, 2800 W and 5000 W models.

An RS-232 / RS-485 communications interface offers complete control integration of the chiller into a higher-level assembly control system where users can remotely request data or send setpoints to the chiller using communication commands. The LCD touchscreen display allows users to easily control temperature setpoints, coolant type, flow and alarm setting. The Nextreme Chiller platform offers several optional features to meet unique application requirements such as flow control and measurement, coolant filtration, high purity plumbing and more.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version